ReleaseWire Connect

Insomnia is the most common sleep disorder and is believed to affect approximately 35% of the global population. The condition can be defined as patient-reported difficultly with sleep initiation or sleep maintenance which can include frequent awakenings, difficulty returning to sleep after awakenings, or awakening too early with inability to return to sleep. Cases of insomnia can be classified on the basis of etiology into primary and secondary (or comorbid) subtypes. The insomnia market is widely genericized creating a competitive environment for new products. As such, the treatment algorithm centers on the generically available nonbenzodiazepines and low-dose sedating antidepressants, despite the launch of numerous novel agents. The value of the insomnia market is set to further decline following the loss of exclusivity for Sunovion/Dainippon Sumitomos Lunesta, the top selling insomnia drug, in April 2014. However, GlobalData expects the launch of two pipeline products from a novel class of drugs to provide growth in the insomnia market as they may address some of the unmet need.

Type 1 diabetes (T1D) is an autoimmune disease that permanently destroys beta cells of the pancreatic islet, which means that the body can no longer produce insulin. Over the last 90 years, insulin therapy has been evolving continuously, as at present, no other treatment can be offered to a patient who is newly diagnosed with T1D. A variety of insulin analogs with different times of action long-acting as well as short or rapid-acting analogs have been on the market for the past decade. In addition, many other developments were happening in parallel, such as glucose monitoring and significant advances in insulin delivery systems. The T1D market will approximately double over the forecast period, growing from $6.6 billion to $13.6 billion.This growth will be fueled by the significant increase in T1D prevalence as well as the uptake of the novel ultra-long-acting insulin analogs, novel ultra-rapid formulations of insulin analogs, and the adjunct therapies for T1D. The launches of these novel products will offset the dip in sales caused by the patent expiries of seven insulin products, and the consequent emergence of biosimilars.

The lupus therapeutics market is dominated by generics and GlaxoSmithKlines Benlysta is the only drug that has gained marketing approval for SLE in more than 50 years. Following Benlystas launch, patients uptake has remained low, but due to its associated high price-tag Benlysta has managed to grow the lupus market in terms of value and is currently the top-selling drug in this market, having generated approximately $265.6m in 2014 in the seven major markets. There is high R&D activity for the development of new therapies for lupus and seven promising biological therapies have the potential to enter the SLE and LN market during the 2012-2022 forecast period. The introduction of new biologic drugs will shape the future competitive landscape and drive growth in the SLE and LN markets.

Oil and Chemicals Storage Industry Outlook in Middle East to 2019 Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Terminals" is a comprehensive report providing information on storage terminals that store crude oil, petroleum products or, chemicals in Middle East. Typical information on terminals includes terminal name, operator name, storage capacity and commodity stored for all active and planned terminals. The report also provides capital expenditure outlook at regional level by year and by key countries for oil and chemical storage terminals till 2019. The report also provides key country comparisons within the region based on contribution to regional oil and chemicals storage capacity. Planned (new build) terminals capacity addition and existing capacity expansions, as announced by the companies have also been included. Further the report also offers recent developments as well as latest tenders and contracts at regional level.

Oil and Chemicals Storage Industry Outlook in Asia and Oceania to 2019 Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Terminals" is a comprehensive report providing information on storage terminals that store crude oil, petroleum products or, chemicals in Asia and Oceania. Typical information on terminals includes terminal name, operator name, storage capacity and commodity stored for all active and planned terminals. The report also provides capital expenditure outlook at regional level by year and by key countries for oil and chemical storage terminals till 2019. The report also provides key country comparisons within the region based on contribution to regional oil and chemicals storage capacity. Planned (new build) terminals capacity addition and existing capacity expansions, as announced by the companies have also been included. Further the report also offers recent developments as well as latest tenders and contracts at regional level.

"Global Planned Oil and Chemicals Storage Industry Outlook to 2019 Capacity and Capital Expenditure Forecasts with Details of All Planned Terminals" is a comprehensive report providing information on planned storage terminals that store crude oil, petroleum products or, chemicals worldwide. Typical information on terminals includes terminal name, operator name, storage capacity and commodity stored for all planned terminals. The report also provides capital expenditure outlook at global as well as regional level by year and by key countries for oil and chemicals storage terminals till 2019. The report also provides key country comparisons within a region and regional comparisons, based on contribution to total storage capacity (regional / global). Planned (new build) terminals capacity addition and existing capacity expansions, as announced by the companies have also been included. Further the report also offers recent developments as well as latest tenders and contracts at regional level.

Global Oil and Chemicals Storage Industry Outlook to 2019 Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Terminals" is a comprehensive report providing information on storage terminals that store crude oil, petroleum products or, chemicals worldwide. Typical information on terminals includes terminal name, operator name, storage capacity and commodity stored for all active and planned terminals. The report also provides capital expenditure outlook at global as well as regional level by year and by key countries for oil and chemical storage terminals till 2019. The report also provides key country comparisons within a region and regional comparisons, based on contribution to total storage capacity (regional / global). Planned (new build) terminals capacity addition and existing capacity expansions, as announced by the companies have also been included. Further the report also offers recent developments as well as latest tenders and contracts at regional level.

Norway Fram Project Panorama, GlobalDatas latest release, presents a comprehensive overview of the asset. This upstream report includes detailed qualitative and quantitative information on the asset, provides a full economic assessment and reflects several parameters including (but not limited to) geological profile, asset development and specific challenges. Based on this analysis, future outlook for the asset is presented with possible trends and related scenarios identifying upside/downside potential.

Norway Oseberg Sor Project Panorama, GlobalData's latest release, presents a comprehensive overview of the asset. This upstream report includes detailed qualitative and quantitative information on the asset, provides a full economic assessment and reflects several parameters including (but not limited to) geological profile, asset development and specific challenges. Based on this analysis, future outlook for the asset is presented with possible trends and related scenarios identifying upside/downside potential.

Norway Grane Project Panorama, GlobalDatas latest release, presents a comprehensive overview of the asset. This upstream report includes detailed qualitative and quantitative information on the asset, provides a full economic assessment and reflects several parameters including (but not limited to) geological profile, asset development and specific challenges. Based on this analysis, future outlook for the asset is presented with possible trends and related scenarios identifying upside/downside potential.